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Critical Limb Ischemia
CRT-200
The Association of Serum Ferritin and 1-Year Mortality in Patients with Critical
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Background: Several studies have examined the association of biomarkers of iron
metabolism with measures of peripheral arterial disease. Few studies, however, have
evaluated the association between biomarkers of iron metabolism and mortality in
critical limb ischemia (CLI).
Methods: Serum ferritin, iron (Fe), and total iron binding capacity (TIBC) were
measured in 82 patients (pts) with CLI underwent endovascular therapy (EVT). The
all enrolled pts had the below-the-knee (BTK) lesions and EVT was successfully
performed. The patients with in-hospital mortality were excluded. The 66 of 82 pa-
tients assessed 1-year clinical follow-up (survivor group¼57, non-survivor group¼9).
Results: There were no signiﬁcant differences in age, gender, hypertension, cere-
brovascular accident, myocardial infarction, current smoking, dyslipidemia, chronic
kidney disease between the survivor and non-survivor groups. As shown in the table,
the survivor group had the higher serum ferritin level than non-survivor. However,
there were no signiﬁcant differences in Fe and TIBC in both groups. When ferritin
was classiﬁed into high and low groups, the high ferritin group had more 1-year
mortality than the low ferritin group (table).
Conclusions: In our study, increased serum ferritin level was associated with higher
1-year mortality in CLI pts who underwent successful EVT.CRT-201
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Introduction: The ankle pressure (AP) and ankle-brachial index (ABI) are inexpen-
sive, sensitive and speciﬁc tests for the diagnosis of peripheral artery disease (PAD). Inpatients with critical limb ischemia (CLI), the decision to perform angiography and
revascularization depends on appropriateness of blood ﬂow to support healing, which
can be predicted by toe pressure (TP) greater than 30 mmHg. This study aimed to
determine if the ABI and/or AP can be used to predict a TP of less than 30 mmHg in
patients with CLI. We hypothesize that the correlation between ABI, AP, and TP
may not be reliable in CLI patients.
Methods: We included consecutive patients with CLI and non-invasive segmental
pressure testing at the University of Southern California between July 2011 and June
2013. Patients were identiﬁed by demographics and classiﬁed by RC; RC 4þ5 (rest
pain and minor tissue loss) compared to RC 6 (major tissue loss). Non-invasive
vascular proﬁle and pressures were recorded. Toe pressures were stratiﬁed as >30 or 
30 mmHg. Statistical correlations were performed by group and strata.
Results: One hundred ﬁfty nine patients were included, mean age was 60.6911.20,
64% male, 53% smokers, 70% diabetic, 32% with CAD and grouped into 126 with
RC 4þ5 (79%) and 33 with RC6 (21%). ABI was similar for RC 4þ5 and RC 6,
0.720.46 vs. 0.580.46, p ¼ 0.16, respectively. Ankle pressures were similar for RC
4þ5 and RC 6 as well, 112.372.71 vs. 107.885.23, p¼0.78, respectively. Toe
pressures differed between the two groups, 41.3343.66 in RC 4þ5, and
18.1522.56 in RC 6, p<0.0001. There was no good correlation between TP and AP
or ABI. Furthermore, the AP and ABI values predictive of a TP<30 are within a
moderate severity PAD range (AP<84 r¼0.36, ABI 0.63 r¼0.42 in RC 4þ5, and
AP<108.28 r¼0.29, ABI 0.8 r¼0.42 in RC 6).
Conclusion: While ABI and AP can be used for routine screening and diagnosis of
PAD, the ABI and AP cannot reliably predict healing potential in patients with CLI.
Further characterization of the disease with toe pressures, lower extremity arterial
proﬁle, tcPO2, or angiography is warranted.
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Purpose: As an adjuvant to sclerotherapy or thermoocclusion, the reduction of target
vein diameter is often desired. Another aim is to restore dilated valve regions. Can this
be accomplished by perivenous ﬂuid injections? We examined a new modality which
was created for this purpose.
Methods: The IntraShape device consists of a safety injection cannula and a viscousﬂuid
containingnative hyaluronic acid andamoderately cross-linkedhyaluronic acid (2%,1:10 -
1:1). The cannula is advanced to a extravenous tip position, then the sharp tip is changed to
blunt so further movements cannot penetrate the vein wall while the viscous ﬂuid is
distributed under ultrasound monitoring. The device was used 1/2013 - 8/2013 in 178
patients with varicosities (diameter 7.1 - 24.8 mm) with injected volumes of 12 - 48 ml.
Results: In one group (n¼98), aiming at adjuvant diameter reduction during sclero-
therapy, the treated segment (length 7 - 14 cm) was totally free of complaints, opposite to
phlebitic complaints in 47/88 comparable segments without adjuvant treatment. In the
second group (n ¼ 80), aiming to valve function restoration, in 62/80 cases the reﬂux
could be stopped during follow-up of 6 months. There were no adverse reactions.
Conclusion: IntraShape is a safe and effective modality to reduce the diameter of
enlarged veins and to restore incompetent vein valves. The long-term effect depends
on the quantity of cross-linked hyaluronan, which increases the costs. As the method
does not require any compression means it is well applicable in patients with severe
peripheral arterial disorders.
